Dr. Okunieff is an internationally respected radiation oncologist and biologist at the University of Florida and a co-founder and the CEO of GainPep, Inc. His research has mainly focused on the mitigation of radiation damage to normal tissues, and he has more than 200 publications in this field. Dr. Okunieff served as the chairman of the steering committee of the Centers for Medical Countermeasures Against Radiation (CMCR) from 2005-2010 and of 7 CMCR symposia sponsored by NIAID, often with the FDA or the Department of Defense.

Previously the branch chief of Radiation Oncology at the NCI (Bethesda, MD), the chair of Radiation Oncology at the University of Rochester (UR), and formerly the director of the University of Florida Health Cancer Center (UFHCC), Dr Okunieff has served as the chair of Radiation Oncology at UF since 2009.

Dr. Zhang is an active entrepreneur and executive in the biotech and pharmaceutical industries with extensive experience ranging from startups to major corporations, including GainPep, Kodia, Panomics, Affymetrix and Bio-Rad. Dr. Zhang brings knowledge and an extensive network in Asia and Emerging Markets to his role at DiaCarta. His substantial experience in R&D management and capability building in Asia and Emerging Markets has a project scope ranging from discovery research to sales and marketing in both US and international markets. He received his Ph.D. from Simon Fraser University in molecular toxicology and pharmacology, was a postdoctoral scholar at the University of Massachusetts, and served as an assistant professor of research at the University of California, Berkeley. Dr. Zhang has published many research papers in leading scientific journals. His inventions are the subject of many patents and patent-pending applications.